Skip to main content
Fig. 3 | Military Medical Research

Fig. 3

From: What benefit can be obtained from magnetic resonance imaging diagnosis with artificial intelligence in prostate cancer compared with clinical assessments?

Fig. 3

Frequencies with which the clinical features were combined with AI models based on MRI in the diagnosis (a) and prediction (b) field of PCa. ADC apparent diffusion coefficient, AI artificial intelligence, D-max the lesion maximum cross-sectional diameter, MR magnetic resonance, MRI-ECE MRI-based extracapsular extension, MRI-LNI MRI-based lymph node involvement, MRI-SVI MRI-based seminal vesicle invasion, PCa prostate cancer, PI-RADS prostate imaging reporting and data system, PSA prostate specific antigen, PSAD prostate specific antigen density

Back to article page